enilconazole has been researched along with Liver Steatosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alarcan, J; Braeuning, A; de Sousa, G; Gioutlakis, M; Katsanou, ES; Konstantinidou, P; Lampen, A; Lichtenstein, D; Luckert, C; Machera, K; Milani, ES; Peijnenburg, A; Rahmani, R; Rijkers, D; Spyropoulou, A; Stamou, M; Stoopen, G; Sturla, SJ; Wollscheid, B; Zucchini-Pascal, N | 1 |
1 other study(ies) available for enilconazole and Liver Steatosis
Article | Year |
---|---|
An adverse outcome pathway-based approach to assess steatotic mixture effects of hepatotoxic pesticides in vitro.
Topics: Adverse Outcome Pathways; Animals; Cell Line, Tumor; Cell Survival; Drug-Related Side Effects and Adverse Reactions; Fatty Liver; Gene Expression; Hep G2 Cells; Humans; Imidazoles; Liver; Liver Neoplasms; Pesticides; Receptors, Cytoplasmic and Nuclear; Risk Assessment; Triglycerides | 2020 |